NM_024312.5:c.637-1G>A
Variant summary
Our verdict is Likely pathogenic. The variant received 6 ACMG points: 6P and 0B. PVS1_ModeratePM2PP5_Moderate
The NM_024312.5(GNPTAB):c.637-1G>A variant causes a splice acceptor, intron change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★).
Frequency
Consequence
NM_024312.5 splice_acceptor, intron
Scores
Clinical Significance
Conservation
Publications
- GNPTAB-mucolipidosisInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- mucolipidosisInheritance: AR Classification: DEFINITIVE Submitted by: Myriad Women’s Health
- mucolipidosis type IIInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics, PanelApp Australia, Genomics England PanelApp
- mucolipidosis type III, alpha/betaInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, G2P, Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 6 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| GNPTAB | NM_024312.5 | c.637-1G>A | splice_acceptor_variant, intron_variant | Intron 6 of 20 | ENST00000299314.12 | NP_077288.2 | ||
| GNPTAB | XM_011538731.3 | c.556-1G>A | splice_acceptor_variant, intron_variant | Intron 6 of 20 | XP_011537033.1 | |||
| GNPTAB | XM_006719593.4 | c.637-1G>A | splice_acceptor_variant, intron_variant | Intron 6 of 18 | XP_006719656.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| GNPTAB | ENST00000299314.12 | c.637-1G>A | splice_acceptor_variant, intron_variant | Intron 6 of 20 | 1 | NM_024312.5 | ENSP00000299314.7 | |||
| GNPTAB | ENST00000549940.5 | c.637-1G>A | splice_acceptor_variant, intron_variant | Intron 6 of 10 | 1 | ENSP00000449150.1 | ||||
| GNPTAB | ENST00000552681.1 | c.271-1G>A | splice_acceptor_variant, intron_variant | Intron 2 of 2 | 1 | ENSP00000449217.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Pseudo-Hurler polydystrophy;C2673377:Mucolipidosis type II Pathogenic:1
In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. ClinVar contains an entry for this variant (Variation ID: 39085). Disruption of this splice site has been observed in individual(s) with mucolipidosis II (PMID: 19617216). This variant is not present in population databases (gnomAD no frequency). This sequence change affects an acceptor splice site in intron 6 of the GNPTAB gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in GNPTAB are known to be pathogenic (PMID: 19617216, 25107912). -
Mucolipidosis type II Other:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at